Wipfli Financial Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Wipfli Financial Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Buy	+39	New	+$512	﹤0.01%	2543

Other funds holding ISEE

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Wipfli Financial Advisors's ISEE Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022: 39 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings.

213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

Wipfli Financial Advisors held 39 shares of IVERIC bio, Inc. Common Stock worth $1K as of Q3 2022.
IVERIC bio, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2543 holding.
213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.